2-(3-bromobenzyloxy)ethanol | 1149358-73-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(3-bromobenzyloxy)ethanol
• 英文别名: 2-[(3-bromophenyl)methoxy]ethanol
• CAS: 1149358-73-5
• 化学式: C₉H₁₁BrO₂
• 分子量: 231.089
• InChiKey: PBPNHGJDBBFUDF-UHFFFAOYSA-N

物化性质

• 沸点：
  317.1±22.0 °C(Predicted)
• 密度：
  1.455±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(3-bromobenzyloxy)ethanol 在 N-溴代丁二酰亚胺(NBS) 、 PS-PPh3 作用下， 以 二氯甲烷 为溶剂， 反应 16.0h， 生成 2-bromoethyl (3-bromophenyl)methyl ether
  参考文献：
  名称：

  Discovery of Novel 1-Azoniabicyclo[2.2.2]octane Muscarinic Acetylcholine Receptor Antagonists

  摘要：

  A novel 4-hydroxyl(diphenyl)methyl substituted quinuclidine series was discovered as a very promising class of muscarinic antagonists. The structure-activity relationships of the connectivity of the diphenyl moiety to the quinuclidine core and around the ring nitrogen side chain are described. Computational docking studies using an homology model of the M-3 receptor readily explained the observed structure-activity relationship of the various compounds. Compound 14o was identified as a very potent, slowly reversible M-3 antagonist with a very long in vivo duration of bronchoprotection.

  DOI：

  10.1021/jm801601v
• 作为产物：
  描述：

  2-(3-溴苯基)-1,3-二氧烷 在 二异丁基氢化铝 作用下， 以 正己烷 、 正庚烷 为溶剂， 生成 2-(3-bromobenzyloxy)ethanol
  参考文献：
  名称：

  AMINE DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

  摘要：

  提供的是胺衍生物化合物、其药物组合物，以及使用所述化合物和组合物治疗眼科疾病和障碍的方法，例如年龄相关的黄斑变性和斯达格特病。

  公开号：

  US20160193181A1

文献信息

• Remote C(sp ³ )−H Acylation of Amides and Cascade Cyclization via N‐Heterocyclic Carbene Organocatalysis
  作者：Qing‐Zhu Li、Rong Zeng、Yang Fan、Yan‐Qing Liu、Ting Qi、Xiang Zhang、Jun‐Long Li

  DOI：10.1002/anie.202116629

  日期：2022.4.4

  An N-heterocyclic carbene catalyzed remote C(sp3)−H acylation of amides was developed, and also combined with a cascade cyclization. Over 120 functionalized δ-amino ketones and isoquinolinones with diverse substituents were synthesized in up to 99 % yield under mild conditions. Preliminary mechanistic investigations shed light on the organocatalytic radical reaction mechanism.

  开发了一种 N-杂环卡宾催化的酰胺的远程 C(sp 3 )-H 酰化，并结合了级联环化。在温和条件下以高达 99% 的产率合成了 120 多种具有不同取代基的功能化 δ-氨基酮和异喹啉酮。初步的机理研究揭示了有机催化自由基反应的机理。
• Compounds - 801
  申请人：Alcaraz Lilian

  公开号：US20110053909A1

  公开（公告）日：2011-03-03

  Spirocyclic amide derivatives of formula I wherein ArCH 2 CH 2 NH— represents a β-adrenoceptor binding group, processes for their preparation, pharmaceutical compositions containing them, a process for preparing such pharmaceutical compositions, their use in therapy, and intermediates for use in their preparation.

  式I的螺环酰胺衍生物，其中ArCH2CH2NH—代表β-肾上腺素受体结合基团，其制备方法，含有它们的药物组合物，制备这种药物组合物的方法，它们在治疗中的应用，以及用于其制备的中间体。
• Amine Derivative Compounds for Treating Ophthalmic Diseases and Disorders
  申请人：Scott Ian L.

  公开号：US20090281149A1

  公开（公告）日：2009-11-12

  Provided are amine derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.

  本发明涉及一种胺衍生物化合物，其制备的药物组合物以及使用该化合物和组合物治疗眼科疾病和障碍的方法，例如老年性黄斑变性和Stargardt病。
• Amine derivative compounds for treating ophthalmic diseases and disorders
  申请人：Acucela, Inc.

  公开号：US08076516B2

  公开（公告）日：2011-12-13

  Provided are amine derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.

  提供了氨基衍生物化合物、其药物组合物，以及使用该化合物和组合物治疗眼科疾病和疾病的方法，例如与年龄相关的黄斑退化和Stargardt病。
• Compounds—801
  申请人：Alcaraz Lilian

  公开号：US08455483B2

  公开（公告）日：2013-06-04

  Spirocyclic amide derivatives of formula I wherein ArCH2CH2NH— represents a β-adrenoceptor binding group, processes for their preparation, pharmaceutical compositions containing them, a process for preparing such pharmaceutical compositions, their use in therapy, and intermediates for use in their preparation.

  式I的螺环酰胺衍生物其中ArCH2CH2NH-表示β-肾上腺素受体结合基团，其制备方法，包含它们的制药组合物，制备这种制药组合物的方法，它们在治疗中的应用以及用于制备它们的中间体。